Back to News
Market Impact: 0.1
XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocks
Source: Nasdaq
Healthcare & Biotech
State Street's Health Care Select Sector SPDR ETF (XLV) has a 0.08% expense ratio, versus 0.58% for the Invesco Pharmaceuticals ETF (PJP), a 50bps annual cost advantage. The comparison highlights XLV's lower ownership costs for healthcare-sector exposure.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
IVZ-0.35
STT0.40
More News
- Street Calls of The Week
- argenx reports positive phase 3 data for autoimmune myositis drug
- Why the prognosis for healthcare stocks is uncertain ahead of Congress’ new makeup
- AtriCure: A New Quality Metric Could Put A Clip In Nearly Every Sternotomy
- J&J presents patient data on nipocalimab for Sjögren’s disease
- Rent-a-grandchild: Businesses offering companions to elderly grow in India